Alzamend Neuro Inc ( ALZN) - Key Metrics
ALZN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0 | -$0.68 | -$0.25 | -$0.25 |
| 2026Q4 | $0 | -$0.86 | -$0.84 | -$0.84 |
| 2026Q3 | $0 | -$0.58 | -$0.46 | -$0.46 |
| 2026Q2 | $0 | -$0.30 | -$0.35 | -$0.35 |
| 2026Q1 | $0 | -$1.28 | -$1.12 | -$1.12 |
ALZN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -0.48 |
| 2026Q4 | 0% | -0.39 |
| 2026Q3 | 0% | -0.93 |
| 2026Q2 | 0% | -2.11 |
| 2026Q1 | 0% | -0.44 |
ALZN
Price: $1.34
52 week price:
Earnings Per Share: -2.03 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 216306
Market Capitalization: 5.2 million